New element order is copied to your clipboard. Please paste it in the Element order variable.
Roche
2
 

 AVENIO Edge System 

3
4

Walk away from manual pipetting

Part of the Roche NGS Automation solution, the AVENIO Edge System1 simplifies the inherent complexities of NGS workflows by automating library preparation, target enrichment, quantification and pooling to optimize lab resources, providing the freedom to walk away with confidence.
 

The AVENIO Edge System is an all-in-one, pre-analytical platform that minimizes manual touchpoints, includes ready-to-load reagents, validated research protocols, on-board quantification capabilities and intuitive software to manage your NGS sample workflows like never before.

5

Optional overline

Simplify NGS sample prep with the AVENIO Edge System

This two minute video highlights the features and benefits of the AVENIO Edge System, including:

  • Intuitive system software for sample and consumables tracking
  • On-deck capabilities including thermal cycling, quantification and pooling
  • Plug-and-play, barcoded reagents powered by KAPA*
  • Efficient, consistent, high-quality results
  • 20 minutes to "set-it-and-forget-it"
  • No specialized knowledge or experience required
6

Optional overline

 

 

Components and run setup


Pierre-Luc Janvier, Senior Manager system development walks through the features and benefits of the AVENIO Edge System. (7:34) 


7

Optional overline


 

AVENIO Edge System Deck Layout


Download the AVENIO System brochure to learn more about the AVENIO Edge System and what sets it apart from the competition.



8

1. The AVENIO Edge System is a Class 1 US IVD and a Class A CE IVDR and is intended for downstream diagnostic applications. 

2. e-Poster P15.032.D, title: ”Introduction of a walk-away automated Roche NGS workflow solution: Integrated KAPA Library Preparation, KAPA Target Enrichment and the AVENIO Edge instrument". MC--08364

3.User-defined protocols created using AVENIO Designer Software are for Research Use Only (RUO) workflows, not for use in diagnostic procedures.

* For Research Use Only. Not for use in diagnostic procedures. The AVENIO Edge System can be used for Research Use Only (RUO) workflows.


9
10

AVENIO Designer Software3


A cloud-based solution that enables laboratory personnel to rapidly customize, convert and modify protocol templates for laboratory-defined workflows on the AVENIO Edge System

• Easy-to-use interface with tunable parameters
• Unparalleled flexibility allows changing workflows at any time
• Validated workflows are pre-populated with recommended parameters and the ability to adjust if needed
• Easily deploy protocols, assess the performance and fine tune until satisfied with the results


11

Results are comparable to manual sample preparation2:


  • Zero manual pipetting for routine use
  • Reliable walk away automation for up to 36 hours


12
To learn more about NGS automation and the newest automated liquid handling technology from Roche, download a free copy of our white paper by completing the form below.
13
Automated Next-Generation Sequencing

NGS is a complex, error-prone, multi-day process that can be a barrier for routine adoption. These workflows are typically carried out using manual pipetting, causing bottlenecks and leading to repetitive stress injuries, if performed routinely. A true walk-away solution will allow researchers to reconceptualize their laboratory – boosting sample capacity, extending the laboratory’s throughput, and freeing up the lab's most valuable resource, its people.
14

Lorem ipsum dolor sit amet consectetur

Lorem ipsum dolor sit amet

Lorem ipsum dolor sit amet, consectetur adipiscing amet

Lorem ipsum dolor sit amet

Lorem ipsum dolor sit amet, consectetur adipiscing amet

Lorem ipsum dolor sit amet

Lorem ipsum dolor sit amet, consectetur adipiscing amet

Lorem ipsum dolor sit amet

Lorem ipsum dolor sit amet, consectetur adipiscing amet

15

Download our white paper, The future of routine diagnostics: automated next generation sequencing

18

COVID-19 Scientific Webinar Series

1st Webinar
Coagulopathy in COVID-19
15:00 - 16:15 CET
Welcome and introduction
Prof. Nicole Juffermans
Thrombotic and haemostatic issues in intensive care, which challenges do we face and what the biomarkers tell us
13:30-13:45
Prof. Edwin J.R. van Beek
Role of Radiology and plasma D-dimer in pathophysiological aspects and treatment of COVID-19
13:30-13:45
Dr. Michelle Sholzberg
Anticoagulation & therapeutic management :
Which treatment fits best and how can we monitor?
13:30-13:45
Q& session
2nd Webinar
Lorem ipsum 08 July 2020
15:00 - 16:15 CET
Welcome and introduction
Prof. James Januzzi
Is a member of the Massachusetts General Hospital Cardiology Division. He is the Hutter Family Professor of Medicine at Harvard Medical School and is on faculty at the Harvard Clinical Research Institute
13:30-13:45
Dr. Raphael Twerenbold
Is an interventional cardiologist and senior physician at the Clinic for Cardiology at the University Hospital Basel
13:30-13:45
Prof. Alexandre Mebazaa
Is Professor of Anaesthesiology and Critical Care Medicine at the Hôpital Lariboisière, University Paris 7, France
13:30-13:45
Dr. Zhou Ning
Associate Professor, Division of Cardiology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology
13:30-13:45
Q& session
3rd Webinar
Lorem ipsum 14 July 2020
15:00 - 16:15 CET
Welcome and introduction
W. Conrad Liles
MD, PhD, University of Washington, Seattle, US
13:30-13:45
Tobias Weinberger
MD, Ludwig Maximilian University of Munich, Munich, Germany
13:30-13:45
Q& session
4th Webinar
Lorem ipsum 16 July 2020
15:00 - 16:15 CET
Welcome and introduction
Prof. Anna Kajdy
Head of Obstetrics Department, St. Sophie's Obstetrics and Gynecology Hospital, Warsaw, Poland
13:30-13:45
Prof. Liona Poon
Clinical Professor, Obstetrics, CUHK, Hong Kong
13:30-13:45
Q& session